Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
The Anti-Phospholipid Antibody Test detects antibodies against phospholipids, helping diagnose antiphospholipid syndrome (APS) and assess the risk of blood clots.
A blood sample is collected from a vein in your arm and analyzed for the presence of antiphospholipid antibodies.
No fasting or special preparation is required. You can eat and drink normally before the test.
Results are usually available within 1-2 days, depending on the laboratory’s processing time.
Discuss any abnormal results with your healthcare provider, who will guide you on further tests or treatment options based on your specific condition.
DEXA Bone Densitometry is an imaging test that measures bone density using low-dose X-rays, helping diagnose conditions like osteoporosis and assess fracture risk.
Wear loose clothing without metal fasteners, and inform your healthcare provider about any medications or recent X-rays.
No, the test is non-invasive and painless. It involves lying on a table while the scanner takes images of your bones.
The scanning process typically takes 10-15 minutes. You will need to remain still during the scan.
Results are usually available within a day or two after the scan. Your healthcare provider will discuss the results and any necessary follow-up.
CRRT is a medical therapy used in intensive care units to manage patients with acute kidney injury (AKI) or severe kidney dysfunction. It involves the continuous removal of waste products and excess fluids from the blood.
CRRT is used when a patient’s kidneys are unable to adequately filter waste and excess fluids from the blood, leading to dangerous levels of toxins and fluid overload.
CRRT differs from hemodialysis in that it is slower and performed continuously over 24 hours or longer periods. Hemodialysis, on the other hand, is intermittent and typically lasts for a few hours.
Yes, CRRT can be used cautiously in patients with heart failure to manage fluid overload and electrolyte imbalances, with careful monitoring of hemodynamic status.
CRRT provides gentler and more gradual fluid and solute removal, making it suitable for hemodynamically unstable patients who cannot tolerate the rapid changes associated with conventional hemodialysis.